We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Nitroso

Nitrosamines are a group of chemical compounds that contain the nitroso functional group (NO) attached to an amine group (-NH). They can form in various ways, including through industrial processes, combustion, and certain chemical reactions, particularly involving nitrites and secondary amines. Nitrosamines are of concern because Many nitrosamines (N-Nitrosamines) are potent genotoxins; some have been classified as possible human carcinogens, although the degree of risk can vary depending on factors such as the amount of exposure and individual susceptibility. Synchemia Research Chemical is dedicated to thoroughly investigating the formation of nitroso impurities in APIs, including those related to the manufacturing processes. This approach indicates a proactive stance toward quality control and regulatory compliance. By exploring all potential sources of nitroso impurities, including those arising from the production processes themselves, Synchemia Research Chemical demonstrates a commitment to ensuring the purity, safety, and efficacy of their pharmaceutical products. Nitrosoamines, including N-Des-methyl Nitroso impurities, are important in pharmaceutical research and development due to their potential impact on drug safety and efficacy. Understanding and controlling the presence of these impurities is crucial for ensuring the quality and safety of pharmaceutical products. Can N-Nitrosamines exist in two different stable forms? N-nitrosamines substituted with two different alkyl groups can exist in two different stable forms distinguishable by several analytical methods. The two rotamers may differ in their overall dipole moment and therefore may posses different chemical and physical properties. Why do I see two peaks when analyzing N-Nitrosamines by HPLC or GC? HPLC and GC)analysis of N-nitrosamines may show two rotamers of the N-nitrosamine as two separate peaks. Whether two peaks are observed depends on the structure of the N-nitrosamine (i.e., symmetric vs. asymmetric) as well as the separation power of the analytical method.
We are the Synchemia Research Chemical specializes in manufacturing and exporting various nitrosoamine compounds, particularly focusing on N-Des-methyl Nitroso impurities of various APIs and nitroso compounds of direct APIs that contain secondary amines. By specializing in the synthesis and export of these compounds, Synchemia Research likely plays a significant role in supporting the pharmaceutical industry's efforts to meet regulatory requirements and ensure the highest standards of quality and safety in drug manufacturing.
download image Download catalogue

Pharmaceutical Reference Standards

N-Nitroso Olanzapine Dimer Impurity
N-Nitroso Olanzapine Dimer Impurity
CAT No SRC-N0143143
CAS No NA
Mol.F. C29H27N7OS2
Mol.Wt. 553.70 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Olanzapine Hydroxy Impurity
N-Nitroso Olanzapine Hydroxy Impurity
CAT No SRC-N0143144
CAS No NA
Mol.F. C12H9N3O2S
Mol.Wt. 259.28 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Olanzapine Hydroxymethylidene
N-Nitroso Olanzapine Hydroxymethylidene
CAT No SRC-N0143145
CAS No NA
Mol.F. C15H17N5O2S
Mol.Wt. 331.39 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Olanzapine Impurity 5
N-Nitroso Olanzapine Impurity 5
CAT No SRC-N0143146
CAS No NA
Mol.F. C15H17N5O2S
Mol.Wt. 331.39 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Olanzapine Impurity 7
N-Nitroso Olanzapine Impurity 7
CAT No SRC-N0143147
CAS No NA
Mol.F. C24H19N7OS2
Mol.Wt. 485.58 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Olmesartan Ethyl Ester
N-Nitroso Olmesartan Ethyl Ester
CAT No SRC-N0143148
CAS No NA
Mol.F. C26H29N7O4
Mol.Wt. 503.56 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Olmesartan Methyl Ketone
N-Nitroso Olmesartan Methyl Ketone
CAT No SRC-N0143149
CAS No NA
Mol.F. C25H27N7O3
Mol.Wt. 473.54 g/mole
INV STATUS CUSTOM SYNTHESIS
N-Nitroso O-Methyl Ether Olmesartan Acid
N-Nitroso O-Methyl Ether Olmesartan Acid
CAT No SRC-N0143150
CAS No NA
Mol.F. C25H27N7O4
Mol.Wt. 489.54 g/mole
INV STATUS CUSTOM SYNTHESIS
1-nitroso-2,3-dihydropyridin-4(1H)-one
1-nitroso-2,3-dihydropyridin-4(1H)-one
CAT No SRC-N0143151
CAS No NA
Mol.F. C5H6N2O2
Mol.Wt. 126.12 g/mole
INV STATUS CUSTOM SYNTHESIS
N- Niroso Desmethyl Rac-Selegiline
N- Niroso Desmethyl Rac-Selegiline
CAT No SRC-N0143152
CAS No NA
Mol.F. C12H14N2O
Mol.Wt. 202.3 g/mole
INV STATUS IN STOCK

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.